A huge collection of 3400+ free website templates www.JARtheme.COM WP themes and more at the biggest community-driven free web design site

ATFirst™ RSV Rapid Test

Rapid Test Kits

IVD Market Growth Looks Favorable

The global market for in vitro diagnostics (IVD) devices is expected to grow 6% annually in the next 5 years, according to a report from Kalorama Information, a market research company based in New York. In 2007, total IVD sales worldwide were almost $42 billion and are projected to reach more than $56 billion by 2012, the company reported.

This forecast of significant growth for the technology is due in part to the projected rise in the 45- to 75-year-old population of many countries. Emerging markets will experience 10%–20% annual growth in IVD device sales, compared with 3%–6% for the rest of the world.

Other trends will also promote rapid growth in the IVD market, the report noted. Developing countries will shift their diagnostic emphasis from infectious diseases to chronic conditions. However, ongoing surveillance will require IVD devices to diagnose H5N1, SARS, and WNV, as well as HIV and other infectious diseases. Rising incomes and living standards in developing countries will also increase demand. China in particular, with its recent entry into the World Trade Organization, is expected to double its use of IVD devices in the next 5 years. Increased privatization of healthcare will likewise add to demand. Future sources of additional demand include research related to the Human Genome Project, as well as patient home monitoring.

North America, excluding Mexico, currently leads in sales, with 44% of market share, followed by the European Union, which has nearly a third of the market.


Contact Us

First Diagnostic Corporation • info@firstdiagnostic.com • www.firstdiagnostic.com



Dublin, Ireland -- (MarketNews) -- 03/17/16 --  First Diagnostic Ltd, a provider of High Quality CE rapid diagnostic testing solutions has announced a successfully trial for a new rapid test for the sexually transmitted infection chlamydia using urine samples that gives results within 10 minutes. 



We appreciate your efforts to improve patient care, physician services, and laboratory efficiency. We know that you will appreciate the value that we bring in delivering diagnostics that do not sacrifice accuracy or ease-of-use. Please contact us for further support.



In addition, First Diagnostic is a party to multiple collaborations, all of which seek to develop new and innovative products to address some of the world’s most serious diseases and conditions. Check Here for new projects...

Legal Statement

As this site can be accessed from various countries around the world.  As First Diagnostic is a International Corporation it's responsibility is limited for such information which may not comply with local country legal process, regulation, registration and usage.  Availability of Products: Reference to any product or service on the site does not constitute an offer to sell or supply that product or service in the country you are viewing from. Specific advice concerning the availability and suitability of any particular product or service should be sought before purchase. We reserve the right to make any changes and corrections to this site as and when we consider it appropriate and without notice.